swainsonine has been researched along with Glioblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Favre, S; Fiaux, H; Gerber-Lemaire, S; Juillerat-Jeanneret, L; Popowycz, F; Schütz, C; Vogel, P | 1 |
| Fiaux, H; Gerber-Lemaire, S; Hoffman, D; Janzer, RC; Juillerat-Jeanneret, L; Kuntz, DA; Rose, DR | 1 |
| Christidou, M; Dexter, DT; Kandanearatchi, A; Maidment, SL; Pilkington, GJ; Rooprai, HK; Rucklidge, GJ; Trillo-Pazos, G; Widmer, W | 1 |
3 other study(ies) available for swainsonine and Glioblastoma
| Article | Year |
|---|---|
Functionalized pyrrolidines inhibit alpha-mannosidase activity and growth of human glioblastoma and melanoma cells.
Topics: alpha-Mannosidase; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Enzyme Inhibitors; Glioblastoma; Humans; Kinetics; Melanoma; Models, Molecular; Molecular Conformation; Pyrrolidines; Structure-Activity Relationship | 2005 |
Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site.
Topics: alpha-Mannosidase; Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Drosophila; Endothelial Cells; Fabaceae; Glioblastoma; Humans; Models, Molecular; Molecular Structure; Pyrrolidines; Structure-Activity Relationship | 2008 |
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Captopril; Cell Adhesion; Cell Movement; Cell Survival; Collagen; Drug Evaluation, Preclinical; Ependymoma; Flavones; Flavonoids; Glioblastoma; Humans; Inhibitory Concentration 50; Matrix Metalloproteinases; Neoplasm Invasiveness; Swainsonine; Tumor Cells, Cultured | 2001 |